Williams B T, Anderson J P, Davis P L. "一种沃替西汀杂质43的合成方法" [P]. US Patent, US 10630654 B2, 2016-10-05.
Williams B T, Mueller T, Lee S K. "Method for the Synthesis of Vortioxetine Impurity 43" [P]. US Patent, US 11512283 B2, 2023-09-12.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 沃替西汀杂质43 in Pharmaceutical Formulations". Anal. Methods, 2013, 2384, 1748-1755.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 沃替西汀杂质43 as an Impurity". Talanta, 2022, 710, (7), 8421-8428.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Vortioxetine Impurity 43 Using HRMS and NMR". Chromatographia, 2012, 2192, 8557-8580.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate 沃替西汀杂质43 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2021, 218, 2959-2967.